PlainRecalls
FDA Drug Moderate Class II Terminated

Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36

Reported: September 8, 2021 Initiated: August 11, 2021 #D-0777-2021

Product Description

Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36

Reason for Recall

CGMP Deviations

Details

Recalling Firm
Granules USA, Inc.
Units Affected
11,450,000 tablets
Distribution
NY
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36. Recalled by Granules USA, Inc.. Units affected: 11,450,000 tablets.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on September 8, 2021. Severity: Moderate. Recall number: D-0777-2021.